Mostly Markets
Stocks/Health Care/Health Care Equipment

Intuitive SurgicalISRG

Health Care Equipment · Sunnyvale, California · In the S&P 500
High qualityPricier than peers
$432.01−3.73%After hours: $432.30 (+0.07%)At the close, 30 Oct · Prices from CNBC, may be delayed
▼ 19.6% over 1 year
Intuitive Surgical over 1 yearDaily close, $, to 30 Oct 2026
$400$500$600Nov2026MarMayJulSep$432.01$400$500$600NovMarJul$432.01
Source: Nasdaq daily closes
Market value$150B
Price to earnings52.3x
Forward P/E37.5x
Dividend yield–
Year to date−23.7%
One year−19.6%
Next earningsNot scheduled
52-week range (closes)
$332.02$592.85

Quality and valuation

How Intuitive Surgical compares with other health care stocks. A description, not a recommendation.

Intuitive Surgical and 7 health care equipment peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: stronger than mostValuation: pricier than most

A stronger business than most health care companies, priced above most of them.

Intuitive Surgical trades at 37.5 times the next 12 months of expected earnings, against a median of 19.1x for the 65 health care stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

  • Revenue grew faster than the sector median: +20.5% vs +7.8%
  • Keeps more of each sale (gross margin): 67.2% vs 65.3%
  • More profitable (operating margin): 28.4% vs 13.3%
  • Turns more of its sales into cash: 31.1% vs 15.9%
ISRG trades at 37.5x forward earnings, above the sector medianForward p/e, Health Care Equipment peers
BSX13.8xBDX15.0xMDT16.1xSYK18.4xABT18.6xEW29.3xIDXX35.1xISRG37.5xSector median 19.1xBSX13.8xBDX15.0xMDT16.1xSYK18.4xABT18.6xEW29.3xIDXX35.1xISRG37.5xSector median 19.1x
Source: CNBC quotes; Mostly Markets
At 52.2x earnings, ISRG is cheaper than its average since Oct 2024Price over the last 12 months of reported (GAAP) diluted EPS
P/EUsual range (±1 s.d.)
40x60x80x100xAverage 67.6x2025202652.2x75x100xAverage 67.6x2025202652.2x
Source: Nasdaq prices; SEC filings

Financials

From Intuitive Surgical's SEC filings, through the quarter ending 30 Sep 2026. Hover or tap a bar for its value.

Revenue grew 21.7% from a year earlierQuarterly revenue, $bn, latest Q3 ’26
$0bn$1bn$2bn$3bnQ4 ’24Q2 ’25Q4 ’25$3.0bnQ3 ’26$0bn$2bnQ4 ’24Q2 ’25Q4 ’25$3.0bnQ3 ’26
Source: SEC filings
Growth sped up to +21.7% last quarterRevenue growth, year on year, %
0%10%20%Q4 ’24Q2 ’25Q4 ’2521.7%Q3 ’260%10%20%Q4 ’24Q2 ’25Q4 ’2521.7%Q3 ’26
Source: SEC filings
Operating margin was 19.4% last quarterOperating income as a share of revenue, %
0%10%20%30%Q4 ’24Q2 ’25Q4 ’2519.4%Q3 ’260%20%Q4 ’24Q2 ’25Q4 ’2519.4%Q3 ’26
Source: SEC filings
Free cash flow was $3.6 billion over 12 monthsQuarterly free cash flow (operating cash flow minus capex), $bn
$0.0bn$0.5bn$1.0bnQ4 ’24Q2 ’25Q4 ’25$1.1bnQ3 ’26$0.0bn$0.5bn$1.0bnQ4 ’24Q2 ’25Q4 ’25$1.1bnQ3 ’26
Source: SEC filings
Last 12 monthsISRGSector median
Revenue growth+20.5%+7.8%
Gross margin67.2%65.3%
Operating margin28.4%13.3%
Free cash flow margin31.1%15.9%
Price to earnings52.3x30.2x

Stories on Intuitive Surgical

We haven't written about Intuitive Surgical yet. Follow it, and its first story will show under My stocks on the front page.

Similar companies

Health Care Equipment, by market value.

CompanyPriceTodayYTDValue
ABTAbbott Laboratories$106.20+1.56%−15.2%$184B
MDTMedtronic$96.54−0.59%+0.5%$123B
SYKStryker$291.86−6.38%−17.0%$112B
BSXBoston Scientific$41.98−1.66%−56.0%$60.84B
BDXBecton Dickinson$197.88−0.23%+27.4%$53.90B
EWEdwards Lifesciences$92.01−2.57%+7.9%$53.03B
IDXXIdexx Laboratories$551.21−4.30%−18.5%$43.42B
GEHCGE HealthCare$76.57+0.20%−6.6%$34.62B